Dialog window

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
      • Natural Health Products
      • Topical OTC Drugs
      • Medical Devices
      • Consumer Products
      • FDA Consulting
      • Veterinary Health Product
    • Health Canada Consultants
      • Regulatory Affairs
      • Pharmacovigilance Services
      • MoCRA
      • Ingredient Compliance
      • CEPA
      • Good Manufacturing Practices (GMP) Training
      • Technology
  • Innovation
  • Articles
  • Contact
Select Page
Navigating MoCRA Compliance: FDA Confirms No Official Verification Certificates Are Issued for Cosmetic Registrations

Navigating MoCRA Compliance: FDA Confirms No Official Verification Certificates Are Issued for Cosmetic Registrations

by Sagarika Sharma | Oct 13, 2026 | FDA, MoCRA

Cosmetic brands and manufacturers navigating e-commerce onboarding have recently faced growing pressure to produce official government documentation proving their regulatory standing. In a September 9, 2026 announcement, the U.S. Food and Drug Administration (FDA)...
OTC Sunscreen Monograph Update: FDA Finalizes Removal of PABA and Trolamine Salicylate

OTC Sunscreen Monograph Update: FDA Finalizes Removal of PABA and Trolamine Salicylate

by Sagarika Sharma | Oct 13, 2026 | FDA, OTC Sunscreen Monograph Update

The U.S. Food and Drug Administration (FDA) has released a final administrative order officially delisting two active ingredients: aminobenzoic acid (PABA) and trolamine salicylate from the over-the-counter (OTC) sunscreen monograph. Following its regulatory...
California bill targets ‘Reel Safe’ Sunscreen Claims

California bill targets ‘Reel Safe’ Sunscreen Claims

by Sagarika Sharma | Oct 13, 2026 | California Cosmetic Regulations

California AB 1744 would prohibit sunscreen manufacturers and sellers from marketing products as ‘reel safe’, ‘reel friendly’, ‘ocean safe’, ‘marine safe’ or similar terms unless the sunscreen contains no chemical...
Washington State Department of Ecology Updates Interim Policy on Lead in Cosmetics

Washington State Department of Ecology Updates Interim Policy on Lead in Cosmetics

by Sagarika Sharma | Oct 13, 2026 | U.S. Regulatory, U.S. State Updates

The Washington State Department of Ecology (Ecology) has released substantial updates to its Interim Policy on Lead in Cosmetics. The revisions eliminate the sunset date for the interim enforcement framework and introduce an active audit mechanism through a mandatory...
FDA Implements Split Payment Framework for FY 2027 OTC Monograph Facility Fees

FDA Implements Split Payment Framework for FY 2027 OTC Monograph Facility Fees

by Sagarika Sharma | Oct 13, 2026 | FDA

The U.S. Food and Drug Administration (FDA) has established a two-part installment plan for Fiscal Year (FY) 2027 Over-the-Counter (OTC) monograph drug facility user fees. Under this payment schedule, regulated drug establishments must remit their annual facility fees...
« Older Entries

Recent Posts

  • Reminder: US FDA Drug Listing Renewals 2026
  • Navigating MoCRA Compliance: FDA Confirms No Official Verification Certificates Are Issued for Cosmetic Registrations
  • OTC Sunscreen Monograph Update: FDA Finalizes Removal of PABA and Trolamine Salicylate
  • California bill targets ‘Reel Safe’ Sunscreen Claims
  • Washington State Department of Ecology Updates Interim Policy on Lead in Cosmetics

Recent Comments

    Archives

    • October 2026
    • September 2026
    • August 2026
    • June 2026
    • April 2026
    • February 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • June 2025
    • May 2025
    • March 2025
    • October 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • December 2023
    • November 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • January 2023
    • December 2022
    • November 2022
    • July 2022
    • June 2022
    • April 2022
    • March 2022
    • October 2021
    • July 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • California Cosmetic Regulations
    • California Office of Environmental Health Hazard Assessment
    • Canadian Environmental Protection Act
    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetic Ingredient Hotlist
    • Cosmetics
    • Cosmetics
    • Environment and Climate Change Canada
    • European Regulatory
    • Events/Company Updates
    • FDA
    • Federal Plastics Registry
    • Health Canada Updates
    • Importation of NHPs
    • Industry Insight
    • Innovation
    • Medical Device
    • Medical Devices
    • MoCRA
    • MoCRA
    • Natural Health Products
    • New Mexico
    • OTC Drugs
    • OTC Sunscreen Monograph Update
    • Our View
    • Prop 65
    • Research/Science/Technology
    • Toxic-Free Cosmetics Act
    • U.S. Regulatory
    • U.S. State Updates
    • Uncategorized
    Copyright © 2025 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY